Showing 731-740 of 20873 results for "".
- Diabetic Retinopathy Tied to Lower Vision-Related Quality of Lifehttps://reachmd.com/news/diabetic-retinopathy-tied-to-lower-vision-related-quality-of-life/2457094/by Lori Solomon Vision-related quality of life (VRQoL) declines with the
- Optimizing Hip and Knee Joint Outcomes: Innovative Approaches and Emerging Therapieshttps://reachmd.com/news/optimizing-hip-and-knee-joint-outcomes-innovative-approaches-and-emerging-therapies/2475606/Orthopedic surgeons face ongoing challenges in optimizing hip and knee joint outcomes, as evolving arthroplasty techniques and emerging therapies reshape treatment paradigms. Recent real-world data on Crowe type 2 dysplasia demonstrate
- Head Injuries, Genetic Makeup Increase MS Risk by up to 18 Timeshttps://reachmd.com/news/head-injuries-genetic-makeup-increase-ms-risk-by-up-to-18-times/2456934/People with a certain type of genetic makeup who’ve have head trauma may have a risk of developing multiple sclerosis (MS) up to nearly 18 times over those without genetic factors or a h
- Tirzepatide Linked to Lower MACE Risk Than Sitagliptinhttps://reachmd.com/news/tirzepatide-linked-to-lower-mace-risk-than-sitagliptin/2488246/Key Takeaways In a large U.S. claims-based cohort using propensity score overlap weighting among adults aged 40 years or older with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide was associated with a lower 1-year risk of major adverse car
- Study Links PCOS With Higher Cardiovascular Disease Riskhttps://reachmd.com/news/pcos-cardiovascular-risk/2487071/Key Takeaways Cardiovascular disease risk was higher in women with PCOS and remained elevated after adjustment for BMI or obesity and education. The association was also present among women with BMI below 25 kg/m2 and no type 2 diabetes. The findings s
- GLP-1 Therapies Show Promise in Treating Bardet-Biedl Syndrome’s Metabolic Challengeshttps://reachmd.com/news/glp-1-therapies-emerging-potential-in-managing-bardet-biedl-syndrome-symptoms/2474266/Once primarily known for their success in managing type 2 diabetes and obesity, GLP-1 receptor agonists are now attracting attention in an entirely different realm: rare genetic disorders. Bardet-Biedl Syndrome (BBS), a multisystemic condition characterized by earl
- NCI Launches Virtual Clinical Trials Officehttps://reachmd.com/news/nci-launches-virtual-clinical-trials-office/2462945/Remote support staff will assist with many types of clinical trials activities. Credit: iStock/shironosov
- Is Gout Hereditary? Understanding the Role of Geneticshttps://reachmd.com/news/is-gout-hereditary-understanding-the-role-of-genetics/2462766/Medically reviewed by David Ozeri, MDGout is a type of inflammatory arthritis characterized by sudden, severe attacks of pain and swelling. It occurs when
- Informed Consumers Increase Dairy Consumptionhttps://reachmd.com/news/informed-consumers-increase-dairy-consumption/2457353/Philadelphia, February 28, 2024 – Although most Americans consume dairy and many dairy foods are rising in popularity, fluid milk consumption has seen a significant decline among US consumers since the 1960s. To reverse this trend—and ensure consumers are getting adequate amounts of da
- Smart Mask Monitors Breath for Signs of Healthhttps://reachmd.com/news/smart-mask-monitors-breath-for-signs-of-health/2468018/Personalized wearable devices that monitor people's health are on the rise. From watches to patches and other types of sensors, these smart devices can monitor heart activity, inflammation levels, and more to help patients better manage their health from their own homes. Now, a new type of w